Mechanism of radiosensitization by inhibitors of poly(ADP-ribose) polymerase (PARP)

被引:0
|
作者
Hegan, Denise C. [1 ]
Glazer, Peter M. [1 ]
机构
[1] Yale Univ, New Haven, CT USA
关键词
D O I
10.1158/1538-7445.AM2011-3893
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3893
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Prostate cancer radiosensitization by targeting poly(ADP-ribose) polymerase
    Zhang, L
    Gokhale, P
    Mewani, R
    Li, BH
    Dritschilo, A
    Soldatenkov, V
    [J]. MOLECULAR THERAPY, 2004, 9 : S234 - S234
  • [22] Current role of poly(ADP-ribose) polymerase inhibitors: which poly(ADP-ribose) polymerase inhibitor and when?
    Vanacker, Helene
    Romeo, Clemence
    Ray-Coquard, Isabelle
    [J]. CURRENT OPINION IN ONCOLOGY, 2019, 31 (05) : 394 - 403
  • [23] MOLECULAR MECHANISM OF POLY(ADP-RIBOSE)POLYMERASE
    MENDOZAALVAREZ, H
    ALVAREZGONZALEZ, R
    [J]. FASEB JOURNAL, 1994, 8 (07): : A1280 - A1280
  • [24] Role of BRCA Mutations in Cancer Treatment with Poly(ADP-ribose) Polymerase (PARP) Inhibitors
    Faraoni, Isabella
    Graziani, Grazia
    [J]. CANCERS, 2018, 10 (12):
  • [25] PARP (Poly ADP-Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer
    Taylor, Amelia M.
    Chan, David Lok Hang
    Tio, Martin
    Patil, Sujata M.
    Traina, Tiffany A.
    Robson, Mark E.
    Khasraw, Mustafa
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (04):
  • [26] Integrating poly(ADP-ribose) polymerase (PARP) inhibitors in the treatment of early breast cancer
    Garber, Haven R.
    Litton, Jennifer K.
    [J]. CURRENT OPINION IN ONCOLOGY, 2019, 31 (03) : 247 - 255
  • [27] Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors
    Thorsell, Ann-Gerd
    Ekblad, Torun
    Karlberg, Tobias
    Low, Mirjam
    Pinto, Ana Filipa
    Tresaugues, Lionel
    Moche, Martin
    Cohen, Michael S.
    Schuler, Herwig
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (04) : 1262 - 1271
  • [28] Design and synthesis of novel, potent poly(ADP-ribose) polymerase (PARP) inhibitors.
    Xu, WZ
    Liu, Q
    Chen, JA
    Ko, YS
    Li, JH
    Lu, M
    Tran, S
    Zhang, J
    Kalish, V
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U53 - U53
  • [29] Poly(ADP-Ribose) Polymerase (PARP) Inhibitors: Exploiting a Synthetic Lethal Strategy in the Clinic
    Yap, Timothy A.
    Sandhu, Shahneen K.
    Carden, Craig P.
    de Bono, Johann S.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2011, 61 (01) : 31 - 49
  • [30] Design, synthesis and SAR evaluation of novel inhibitors of poly(ADP-ribose)polymerase (PARP).
    Musick, KY
    Weintraub, PM
    Eastwood, P
    Mehdi, S
    Koehl, J
    Kominos, D
    Schreuder, H
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U22 - U22